Recently, ARHGAP17, a Cdc42-specific GAP, was identified as a negative regulator of invadopodia in breast cancer cells by shRNA screening for Rho GAPs (Kreider-Letterman et al., 2023). This evidence concerns the gene CDC42 and breast cancer.